Lima Memorial Health System Logo
Approximate ER WAIT TIME WAIT TIME MACRO

Health Library

Inflammatory bowel disease - series
Site Map

Inflammatory bowel disease - series

Inflammatory bowel disease - series

Normal anatomy

The gastrointestinal tract starts at the mouth, which leads to the esophagus, stomach, small intestine, colon, and finally, the rectum and anus. The GI tract is basically a long, hollow, muscular tube through which food passes and nutrients are absorbed.


Indications

Indications

Inflammatory bowel disease is a condition in which the innner lining of the GI tract becomes inflamed, leading to ulcers and bleeding. The colon is most often the site of this inflammation. Patients with inflammatory bowel disease have symptoms that include diarrhea, abdominal pain, infections, and bleeding. Inflammatory bowel disease falls under two main headings: Crohn's disease, which involves the entire GI tract, and ulcerative colitis, which involves only the colon. The cause of inflammatory bowel disease is unknown.


Incision

Incision

The primary treatment for inflammatory bowel disease involves medications, such as steroids, which can decrease inflammation and resolve symptoms. Occasionally, if segments of bowel are very inflamed and are not responding to medication, surgery to remove these segments may be necessary. While the patient is deep asleep and pain-free (general anesthesia), an incision is made in the midline of the abdomen.


Procedure

Procedure

The inflamed segment of the colon or small intestine is removed and the healthy ends are sewn back together.


Aftercare

Aftercare

The removal of one section does not preclude recurrence of symptoms in other areas of the intestine. The course of inflammatory bowel disease is often variable: Some patients experience only mild symptoms, while others have more debilitating symptoms.


BACK TO TOP

Review Date: 1/24/2025  

Reviewed By: Jenifer K. Lehrer, MD, Gastroenterologist, Philadelphia, PA. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.

adam.com

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.